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Methods: June 2008 to June 2013, 1620 cases of diabetes patients underwent coro-
nary angiography, using quantitative coronary analysis method (QCA) to cumulate the
sum of the respective integral stenosis. Coronary artery lesion is expressed by ACC/
AHA lesion types. According to the 2007 “China Adult dyslipidemia prevention
guide” TG  2.26mmol/L, HDL-C  0.88mmol/L deﬁned as high TG/ low HDL-C
level.
Results: (1) 1620 cases of diabetic patients with high TG/ and low HDL-C in
patients was 1069 cases (65.99%). (2) The coronary stenosis score of diabetic
patients with high TG/ and low HDL-C is 10.53.6; The coronary stenosis score
of diabetes mellitus was 73.5, there are signiﬁcant differences between two
groups (P<0.05). (3) in Diabetic patients with high TG/ and low HDL-C, the
lesions type of B2, C is accounted for 69.6%; in diabetes mellitus group, the
lesions type of B2, C is accounted for 47.6%. (4) Stepwise regression analysis
showed that, there is a linear relation between coronary artery stenosis degree
integral and TG, HDL-C.
Conclusions: High TG / low HDL-C may constitute a major cardiovascular risk of
diabetes residual dyslipidemia type.GW25-e0243
Different levels of glycosylated hemoglobin will inﬂuence severity and long-term
prognosis of coronary heart disease patients with stent implantation
Wang Jing, Tang Chengchun
Zhongda Hospital of Southeast University Medical School, Nanjing, China
Objectives: To investigate the relationship between glycosylated hemoglobin
(HbA1c) levels and severity and long-term prognosis of coronary heart disease (CHD)
with stent implantation.
Methods: 2825 consecutive patients with stent implantation were stratiﬁed into 3
groups base on the levels of HbA1c: low HbA1c group (group A, HbA1c<5.92%,
n¼1035), moderate level HbA1c group (group B, 5.92% <HbA1c<6.82%, n¼1025)
and high HbA1c group (group C, HbA1c >6.82%, n¼765).The impact of HbA1c on
the gensini score and long-term prognosis of CHD with stent implantation were
observed.
Results: After an average of 1 years of follow-up of 2825 patients in a hospital cohort.
Participants with low (<41 mmol/mol or 5.9%) or high (> 51 mmol/mol or 6.8%)
HbA1c had a higher risk of MACE, TLR than that of participants with moderate
(41-51 mmol/mol or 5.9-6.8%) HbA1c after adjusting for multiple potential con-
founders (hazard ratios ¼ 1.505, 1.478 and 1.626, 1.522, respectively). Analysis of
HbA1c as a continuous variable showed that each XX mmol/mol (1%) increase of
HbA1c was signiﬁcantly associated with a decreased risk of MACE and TLR of
53.5% and 54.2% in those with an HbA1c level of less than 41 mmol/mol (5.9%) and
with an increased risk of MACE and TLR by 9.5% and 9.2% in those with an HbA1c
level of 41 mmol/mol (5.9%) or higher, suggesting a U-shaped association between
HbA1c and risk of MACE and TLR.
Conclusions: HbA1c levels, either as a continuous variable or a categorical variable,
has a U-shaped correlation with MACE and TLR in CHD patients with stent im-
plantation, even after adjustment for multiple confounders.GW25-e0404
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Objectives: To evaluate the impact of type 2 diabetes mellitus co-morbidity on
hospitalization costs in patients with acute myocardial infarction (AMI).
Methods: Retrospective analysis of data from the case retrieval system of Qilu
Hospital of Shandong University located in Jinan city of Shandong Province was
conducted in patients with AMI from January 1, 2011 to December 31, 2012.
Results: Stent is an important factor affecting total costs of hospital admission
(b¼0.663, P¼0.000), total costs per hospital day (b¼0.561, P¼0.000), treatment
costs (b¼0.418, P¼0.000) and treatment costs per hospital day (b¼0.378,
P¼0.000) of AMI patients over follow-up period (duration of hospital stay only).
Stent is also a protective factor to prevent AHF over follow-up period (OR¼0.247,
95%CI: 0.125-0.487, P¼0.000). Diabetes group’s inpatient incidence of acute heart
failure (AHF) is higher than non-diabetes group’s (14.0% vs. 6.8%; P¼0.002).
Implementation of PCI can reduce inpatient incidence of AHF of diabetic (23.3%
vs. 4.1%, P¼0.000) and non-diabetic (14.5% vs. 2.8%, P¼0.000) patients, and
elevate inpatient incidence of event-free survival of diabetic (77% vs. 94%,
P¼0.000) and non-diabetic (86% vs. 94%, P¼0.002) patients. Diabetic patients’
incremental cost-effectiveness ratio (ICER) estimate for implementing PCI is higher
than non-diabetic patients’.C148 JACC Vol 64/16/Suppl C j October 16–1Conclusions: Diabetes does not make an impact on total hospitalization costs and
treatment costs of AMI patients, and stent is an important factor affecting hospi-
talization costs over follow-up period. From the perspective of reduction in the
inpatient incidence of AHF and increased inpatient incidence of event-free survival
after implementing PCI, implementation of PCI after an AMI in patients with dia-
betes mellitus has a higher level of cost-effectiveness than those without diabetes
mellitus.GW25-e0507
The effectiveness and safety of percutaneous coronary intervention on
unprotected left main coronary arterial stenosis patients
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Objectives: To evaluate the effectiveness and safety of percutaneous coronary
intervention (PCI) on unprotected left main coronary arterial (UMLCA) 2 years after
PCI owing the UMLCA PCI is a challenging technique.
Methods: A total of 90 patients with UMLCA stenosis receiving PCI through angi-
ography guidance were enrolled from Jan. 2008 to Jan. 2012. The primary endpoint
was a composite of major adverse cardiac cerebral events (MACCE), including car-
diovascular death, myocardial infarction, target vessel revascularization and all-cause
mortality at 2 years following interval.
Results: Among the total 90 patients, male patients were 74.4%, the mean age was
(63.415.2) years old. The left main ostial, shaft and bifurcation lesions were
15.6%, 25.5% and 58.9%, respectively. The UMLCA stenosis severity was
(74.612.8) %. The mean Syntax score was (19.65.2). All 90 patients were stented
successfully and 108 drug eluting stents were implanted. The mean stents length was
(16.32.4) mm and mean dilated stents diameter was (3.91.4) mm. 55 patients
(61.1%) received 1 stent implantation and 35 patients (38.9%) received 2 stent
implantation. After followed 24 months, the all-cause mortality was 5.5%, the target
vessel revascularization was 22.6% vs. 10.8% in double stents and single stent
strategy respectively, P<0.01.
Conclusions: PCI for UMLCA stenosis is safety and effectiveness. A strategy of 1 or
2 drug-eluting stents implantation for UMLCA stenosis reveal the single stent strategy
was more effective in following 2 years period. The double stents in UMLCA with
bifurcation lesions did not improve the 2-year MACCE rates. The 1 or 2 strategy of
stents implantation by the operator decision was associated with improved results, the
coronary artery bypass grafting was more effective for the UMLCA with bifurcation
lesions.GW25-e0852
Pro- BNP in patients with pulmonary vein electrical isolation predicts the
recurrence of late atrial ﬁbrillation after ablation in paroxysmal and
persistent atrial ﬁbrillation
Zhang Bo, Huang Lan
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Objectives: To determine the protective value of serum Pro-BNP in the recurrence of
late atrial ﬁbrillation after pulmonary vein isolation in paroxysmal and persistent atrial
ﬁbrillation.
Methods: 94 patients in the present study had symptomatic paroxysmal AF and
had failed to respond to at least one anti-arrhythmic drug. All patients under-
went electrophysiological study and circumferential pulmonary vein isolation
(CPVI) till to achieve PV isolation. Cardiac structure and function were
measured with 2-D echocardiogram, and the cardiac biomarker N-terminal pro-
brain natriuretic peptide (NT-pro-BNP) was measured before ablation and at
long-term follow-up.
Results: After follow-ups for 12 months, 72 patients did not recurred any late atrial
ﬁbrillation. There was no signiﬁcant difference of atrioventricular structure and
function parameters and pro-BNP in patients between success group and recur-
rence group before ablation. Left atrial dimension (LAD) and pro-BNP levels fell
only after successful AF ablation and NT-pro-BNP after 12 months follow-up. A
decrease up of > 25% of the baseline value of NT-pro-BNP at follow-up had a
speciﬁcity of 90.6%, a sensitivity of 80.6 and a accuracy 84.04% for ablation
success.
Conclusions: A decrease in NT-pro-BNP after CPVI may be a marker of long-term
ablation success.GW25-e1070
The value of adiponectin and interleukin-18 in predicting the vascular
remodeling in coronary in-stent restenosis after percutaneous coronary
intervention procedure
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Objectives: To discuss the relationship between the concentration of serum adipo-
nectin, interleukin-18 and the in-stent restenosis after percutaneous coronary inter-
vention procedure (PCI).
Methods: PCI procedure was carried out in 58 patients with coronary artery disease
in hospital. After the procedure,both coronary angiography and optical coherence
tomography (OCT) were conducted during follow-up period. Base on the coronary
angiography ﬁndings, in-stent restenosis (ISR) was conﬁrmed in 7 cases with a total
of 12 lesions (ISR group), while no in-stent restenosis (non-ISR) was seen in 51
cases with a total of 65 lesions (non-ISR group). The measurement indexes contain
the maximal neointimal hyperplasia thickness of stent, minimal lumen cross-
sectional area, stent cross-sectional area. And then we can calculate the neointimal
hyperplasia area, the percentage of the area of the neointimal, diameter stenosis ratio
and so on. Before and after the treatment, serum APN and IL-18 levels were
determined. The changes in serum APN and IL-18 levels after PCI in each group
were compared.
Results: Both the maximal neointimal hyperplasia thickness of stent and neointimal
hyperplasia area were signiﬁcantly larger, while the LA was signiﬁcantly smaller, in
ISR group than those in non-ISR group (P<0.05). Compared with patients without
restenosis and those with restenosis before PCI, the patients with coronary in-stent
restenosis showed signiﬁcantly increased serum IL-18 after PCI (P<0.05) and reduced
serum APN after PCI (P<0.05). In ISR group, the concentration of IL-18 before PCI
were obviously increased than that after PCI (P<0.05). In non-ISR group, the con-
centration of APN before PCI were obviously increased than that after PCI (P<0.05).
The percentage of the area of the neointimal was positively correlated to IL-18 and
inversely to serum APN.
Conclusions: After PCI the concentration of serum APN and IL-18 bear a close
relationship to the degree of restenosis.
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Objectives: In-stent restenosis (ISR) of drug eluting stent (DES) is currently one of
the most challenging situations in interventional cardiology since it is occurring with
increasing frequency. Recent studies found obvious morphological difference of tissue
characteristics between early (1 year after stenting) and late (>1 year after stenting)
ISR lesions. This study aimed to compare the efﬁciency of repeated DES for early and
late ISR of DES.
Methods: All patients undergoing repeated DES for ISR of DES in our hospital were
identiﬁed from October 2008 to December 2011, who were divided into early and late
ISR group according to ISR occurring within or more than 1 year after initial DES
implantation. Clinical target lesion revascularization (TLR) was the primary endpoint.
The secondary endpoint was major adverse cardiovascular events (MACE) including
all-cause death, myocardial infarction (MI) and TLR.
Results: Total 107 patients undergoing repeated DES for ISR of DES were identiﬁed
and enrolled in our study: 44 patients in early ISR group and 63 patients in late ISR
group. Overall TLR rate was 25.2 %. Early ISR group had higher TLR rate than late
ISR group (43.2% vs. 12.7%, P<0.001). MACE of early ISR group was higher than
that in late ISR group (47.73% vs. 15.87%, P< 0.001), which attributed to the sig-
niﬁcant difference of TLR between the two groups. Multivariable analysis found that
early ISR (Odds ratio (OR) ¼6.47, 95% Conﬁdence interval (CI): 2.262-18.504;
P< 0.001) was the only independent predictor of TLR during a median follow-up of
19.6 [11.4-22.0] months.
Conclusions: Repeated DES implantation is safe and efﬁcient for treatment of late
ISR of DES but is not appropriate for early ISR of DES.
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XTRM-FIT Coronary Stent System in combination with Tiroﬁban in the
treatment of elderly Acute Coronary Syndrome
Liu Peiliang, Li Xuan, Miao Lei
Center emergency cardiovascular disease, JinQiu Hospital of Liaoning Province
Objectives: This research of XTRM-FIT Coronary Stent System in combination with
Tiroﬁban in the treatment of 35 cases of elderly Acute Coronary Syndrome (ACS) had
a satisfactory result. The report is as follows:
Methods: Choose ACS 60 cases under PCI, according to random number table the
test was randomly divided into two groups: Group A (XTRM - FIT + Tiroﬁban) had
30 cases, male 16 cases, female 14 cases; Group B (XTRM - FIT) had 30 cases, male
15 cases, female 15 cases. Choose the same stent brand for each patient. There were
no statistically signiﬁcant in difference compared (P>0.05). According to the angi-
ography results of coronary artery stenosis degree, the degree of stenosis 75% was
deﬁned as PCI treatment lower limit. The size of stent was chose by clinical doctor.
After coronary artery guiding wire through Occlusion lesions, then give injection
load for Tiroﬁban 10 mg/kg, the intravenous injection is completed within 3 minutes.
For the 70-year-old or older patients or stroke patients within 2 years, the dosing is
reduced 20%, then the micro-injection pump continuous to inject 36h with 0.15
mg/(kg.min). In the process of PCI, intravenous injection heparin 50 U/kg, an extra
1000 U with each more than 1h.The presence of stenocardia, any abnormal changes
of electrocardiogram, myocardial enzyme, platelet count, hemoglobin, hematokritJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/C(HCT), etcoutpatient follow-up or telephone follow-up for 30 days about the inci-
dence of stenocardia, the incidence of subacute thrombosis, the rate of MACE,
rehospitalization rate. Using SPSS 10.0 statistical software for data processing.
P<0.05 for the difference was statistically signiﬁcant.
Results: In the two groups, there were no statistically signiﬁcant (P>0.05) for the
number of target vessel, Stenosis degree, the number of stent implantation, the Peak
pressure of stent release, operating time, PCI success rate, etc. The rate of acute in-
stent thrombosis occurred for the two groups were 0 and 3.33% respectively
(P<0.05).Bleeding complications: between the two groups (P>0.05).The platelet
count, hemoglobin, Hematokrit (HCT) change. Between the two groups (P>0.05).
30-day follow-up results after PCI: the rate of target vascular reconstruction, sub-
acute thrombosis, MACE rate and rehospitalization between the two groups
(P<0.05).
Conclusions: XTRM-FIT coronary stent system, is the latest generation coronary
artery stent which is manufactured by Blue Medical Devices B.V (the
Netherlands). It adopts unique “Dylyn” biological coating technology, reduces the
intravascular endothelial hyperplasia and inﬂammatory reaction. Short, both
XTRM-FIT Coronary Stent System in combination with Tiroﬁban and only stent
implantation all have good security, but have signiﬁcant differences for effec-
tiveness. For the combination therapy, the incidence of stenocardia, MACE rate,
the incidence of acute and subacute thrombosis and hospitalization rates, etc. were
signiﬁcantly lower.GW25-e2147
Impact of recombinant brain natriuretic peptide for prevention of contrast-
induced nephropathy in patients with chronic kidney disease undergoing
non-emergent percutaneous coronary intervention or coronary angiography
Liu Jinming, Li Yongjun
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Objectives: To investigate the effect of BNP for prevention of CIN in patients with
unstable angina (UA) and chronic kidney disease (CKD) undergoing elective percu-
taneous coronary intervention (PCI) or coronary angiography (CAG).
Methods: Patients with UA concomitant CKD (15ml/min/1.73 m2GFR60ml/
min/1.73m2) who would receive elective PCI or CAG were randomly assigned to
BNP group (0.005mg/kg/min within 24 hours before contrast media exposure in
addition to saline; n¼106) or the control group (only hydration with saline for 12h
before and 12h after procedure, n¼103). Cystatin C, serum creatinine (Scr) levels
and creatinine clearance rate (CCr) were collected before procedure, at 24h, 48h,1
week and 1 month after procedure. The primary outcome measure was the incidence
of CIN deﬁned by a relative (25%) or absolute (0.5 mg/dl; 44mmol/L) increase in
serum creatinine from baseline within 48 hours. The secondary endpoint was the
changes in the Scr, CCr and serum cystatin C concentrations before and after
procedure.
Results: Baseline characteristics of patients were similar for both groups. The
incidence of CIN was signiﬁcantly lower in patients on rhBNP infusion than those
on hydration (6.6% vs 16.5%, P<0.05). There was a more signiﬁcant deterioration
in the control group than in the BNP group of Ccr, Cystatin C and Scr from 48 hour
to 1 week (P<0.05). The CCr gradually deteriorated in both groups, but it was
lower and recovered faster in patients on rhBNP. Multivariate logistic regression
revealed the use of >100ml of contrast volume (odds ratio: 4.36; P¼0.004) and
BNP administration (odds ratio: 0.21; P¼0.006) to be independently predictive
of CIN.
Conclusions: In addition to hydration, exogenous administration of rhBNP before
contrast media exposure was effective in decreasing the incidence of CIN.GW25-e2164
Safety and efﬁcacy of immediate Rotational Atherectomy In nondilatable
calciﬁed coronary leSions complicated by coronary artery dissEction (RAISE)
Sun Dongdong, Li Chengxiang
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Objectives: To examine the safety and efﬁcacy of immediate rotational atherectomy
(RA) in nondilatable calciﬁed coronary lesions complicated by coronary dissection
during percutaneous coronary intervention (PCI).
Methods: One hundred and nighty-eight patients with severe coronary calciﬁcation
underwent PCI, and were randomized into immediate (n¼105) or delayed RA group
(n¼93) when coronary dissections occur.
Results: At a follow-up of 4 years, event-free survival rates were not statistically
different between the immediate and delayed RA group (81.9% vs 80.6%, P¼0.820).
Rates of PCI- and RA-related MACE and severe RA-related complications were not
statistically different between the two groups. Luminal loss was not signiﬁcantly
different between the immediate and delayed RA group as evaluated by quantitative
coronary angiography and IVUS. Two cases in the delayed RA group experienced
myocardial infarction during the 4-week waiting.
Conclusions: This study indicates that immediate rotational atherectomy (RA) during
percutaneous coronary intervention (PCI) is safe and effective in patients with coro-
nary artery dissection.ardiovascular Disease Clinical Research C149
